Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue Haupt

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Cell Cycle (Georgetown, Tex.)|May 10, 2013
Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent mannerSue Haupt, Catherine Mitchell, Vincent Corneille, et al.
Biochemistry|April 16, 2013
c-Abl phosphorylates E6AP and regulates its E3 ubiquitin ligase activityAi-Leen Chan, Tamar Grossman, Valentina Zuckerman, et al.
Redox Biology|September 10, 2017
Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosisShashank Masaldan, Sharnel A S Clatworthy, Cristina Gamell, et al.
BMC Urology|October 29, 2020
Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case reportScott G Williams, Han Xian Aw Yeang, Catherine Mitchell, et al.
Molecular & Cellular Proteomics : MCP|February 22, 2018
Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer CellsTwishi Gulati, Cheng Huang, Franco Caramia, et al.
Gut|July 19, 2015
APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinomaDavid S H Liu, Matthew Read, Carleen Cullinane, et al.
Human Mutation|March 7, 2019
A quantitative model to predict pathogenicity of missense variants in the TP53 geneCristina Fortuno, Arcadi Cipponi, Mandy L Ballinger, et al.
Molecular Cancer Therapeutics|July 28, 2021
SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than <i>TP53</i> Mutation StatusKenji M Fujihara, Mariana Corrales Benitez, Carlos S Cabalag, et al.
Oncotarget|November 28, 2014
Role of p53 in the progression of gastric cancerRita A Busuttil, Giada V Zapparoli, Sue Haupt, et al.
Oncotarget|May 7, 2017
E6AP promotes prostate cancer by reducing p27 expressionDinesh Raghu, Piotr Jan Paul, Twishi Gulati, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Cell Cycle (Georgetown, Tex.)|May 10, 2013
Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent mannerSue Haupt, Catherine Mitchell, Vincent Corneille, et al.
Biochemistry|April 16, 2013
c-Abl phosphorylates E6AP and regulates its E3 ubiquitin ligase activityAi-Leen Chan, Tamar Grossman, Valentina Zuckerman, et al.
Redox Biology|September 10, 2017
Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosisShashank Masaldan, Sharnel A S Clatworthy, Cristina Gamell, et al.
BMC Urology|October 29, 2020
Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case reportScott G Williams, Han Xian Aw Yeang, Catherine Mitchell, et al.
Molecular & Cellular Proteomics : MCP|February 22, 2018
Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer CellsTwishi Gulati, Cheng Huang, Franco Caramia, et al.
Gut|July 19, 2015
APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinomaDavid S H Liu, Matthew Read, Carleen Cullinane, et al.
Human Mutation|March 7, 2019
A quantitative model to predict pathogenicity of missense variants in the TP53 geneCristina Fortuno, Arcadi Cipponi, Mandy L Ballinger, et al.
Molecular Cancer Therapeutics|July 28, 2021
SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than <i>TP53</i> Mutation StatusKenji M Fujihara, Mariana Corrales Benitez, Carlos S Cabalag, et al.
Oncotarget|November 28, 2014
Role of p53 in the progression of gastric cancerRita A Busuttil, Giada V Zapparoli, Sue Haupt, et al.
Oncotarget|May 7, 2017
E6AP promotes prostate cancer by reducing p27 expressionDinesh Raghu, Piotr Jan Paul, Twishi Gulati, et al.
Pageof 6